Etrol(SZ:300370)2020-10-28 16:00Financial Performance - Operating revenue for the reporting period was CNY 82,223,744.77, a decrease of 71.85% compared to the same period last year[7]. - Net profit attributable to shareholders was a loss of CNY 62,297,649.98, representing a decrease of 8,897.53% compared to the same period last year[7]. - Revenue for the reporting period was ¥235,389,755.94, a decrease of 66.44% compared to ¥701,480,371.21 in the same period last year, primarily due to the impact of the pandemic on business implementation and settlement delays[21]. - Net profit for the period was a loss of ¥171,332,371.32, representing a decline of 18,368.42% compared to a profit of ¥937,860.96 in the previous year[21]. - Total operating revenue for Q3 2020 was CNY 82,223,744.77, a decrease of 71.8% compared to CNY 292,064,474.16 in the same period last year[41]. - The net loss for the quarter was ¥171,332,371.32, compared to a net profit of ¥937,860.96 in the previous year, reflecting a significant decline in profitability[49]. - The company reported a total comprehensive loss of ¥170,948,728.00 for the quarter, compared to a comprehensive income of ¥961,778.62 in the previous year[50]. Assets and Liabilities - Total assets at the end of the reporting period decreased by 8.79% to CNY 3,084,679,574.16 compared to the end of the previous year[7]. - Total liabilities decreased from CNY 2,385,727,706.53 to CNY 2,263,148,515.35, a reduction of about 5.1%[35]. - The company's total equity decreased from CNY 996,152,353.31 to CNY 821,531,058.81, a decline of approximately 17.6%[36]. - The total current assets as of September 30, 2020, were ¥1,590,206,593.37, down from ¥1,844,843,855.10 at the end of 2019[33]. - The total assets of the company were CNY 2,550,102,800.56, slightly down from CNY 2,561,234,228.67 year-on-year[42]. - Current liabilities reached CNY 2,166,129,412.85, while total liabilities were CNY 2,385,727,706.53[63]. Cash Flow - The net cash flow from operating activities decreased by 57.07% to CNY 19,629,960.89 compared to the previous period[9]. - Cash flow from operating activities was negative at ¥4,159,606.97, a decrease of 102.07% from ¥201,172,606.42 in the same period last year, mainly due to reduced cash collections[21]. - Cash inflow from operating activities decreased to ¥576.36 million from ¥1,147.03 million, a decline of approximately 49.7% year-over-year[55]. - Total cash outflow from operating activities was ¥580.52 million, compared to ¥945.86 million in the previous period, a reduction of about 38.6%[55]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 67,097[12]. - The largest shareholder, Yu Ling, holds 16.44% of the shares, with 136,471,052 shares pledged[13]. - The total number of restricted shares at the beginning of the period was 258,136,311, with 242,981,121 remaining at the end of the period, indicating a reduction of 15,155,190 shares[18]. - The company did not conduct any repurchase agreements among the top 10 shareholders during the reporting period[14]. - The top 10 shareholders held a total of 249,631,304 restricted shares, with 241,317,028 shares released during the period[18]. Expenses and Losses - Operating costs decreased by 59.08% to ¥201,372,544.03 from ¥492,053,410.53, also attributed to pandemic-related delays[21]. - Financial expenses surged to CNY 36,156,279.62, up 55.5% from CNY 23,262,374.66 year-on-year[42]. - The company reported a significant increase in credit impairment losses, totaling ¥-13,173,055.39, a rise of 285.70% compared to ¥-3,415,398.84, due to new accounting policies and slow collections impacted by the pandemic[21]. Other Financial Metrics - Basic earnings per share were -CNY 0.0651, a decrease of 9,400.00% compared to the same period last year[9]. - The weighted average return on net assets was -7.31%, a decrease of 7.39% compared to the previous period[9]. - The company reported non-operating income of CNY 4,942,481.71 from government subsidies during the reporting period[10]. - Research and development expenses for Q3 2020 were CNY 5,167,179.02, a decrease of 14.5% from CNY 6,048,253.76 in Q3 2019[42].